Advances in diagnostic and treatment options in patients with fibromyalgia syndrome

QR Code

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome

Ali Gur1, Pelin Oktayoglu21Department of Physical Medicine and Rehabilitation, Medical Faculty, Gaziantep University, Gaziantep, Turkey; 2Department of Physical Medicine and Rehabilitation, Batman State Hospital, Batman, TurkeyAbstract: Fibromyalgia (FM) is characterized as a chronic, painful, nonin...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ali Gur, Pelin Oktayoglu
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2009
Sujets:	Diseases of the musculoskeletal system RC925-935
Accès en ligne:	https://doaj.org/article/76e541bfb36b4aea95b4bcaf9ebe4e97
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
par: Jill M Recla
Publié: (2010)

Management strategies for fibromyalgia
par: Le Marshall KF, et autres
Publié: (2011)

Childhood risk factors for developing fibromyalgia
par: Olivieri P, et autres
Publié: (2012)

Current options for the treatment of Paget&rsquo;s disease of the bone
par: Daniela Merlotti, et autres
Publié: (2009)

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome
par: Pierre Quartier
Publié: (2011)

Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin- associated periodic syndromes
par: Bachove I, et autres
Publié: (2014)

The patient perspective: arthritis care provided by Advanced Clinician Practitioner in Arthritis Care program-trained clinicians
par: Warmington K, et autres
Publié: (2015)

Recent advances in neutralizing the IL-6 pathway in arthritis
par: Charles J Malemud
Publié: (2009)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control
par: Taylor SD, et autres
Publié: (2013)

Poor Prognosis of COVID‐19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross‐Sectional Population Study Of 252 119 Patients
par: Isabela Maria Bertoglio, et autres
Publié: (2021)

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
par: Jeffrey R. Curtis, et autres
Publié: (2021)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
par: Michaël Doumen, et autres
Publié: (2021)

Correction to: Extending the straight leg raise test for improved clinical evaluation of sciatica: validity and diagnostic performance with reference to the magnetic resonance imaging
par: Janne Pesonen, et autres
Publié: (2021)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
par: Fabrizio Cantini, et autres
Publié: (2009)

The epidemiology and treatment of gout
par: McGill NW
Publié: (2011)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
par: Roy Fleischmann
Publié: (2009)

Patient and clinician experiences and opinions of the use of a novel home use medical device in the treatment of peripheral vascular disease - a qualitative study
par: Charlotte E. Sedgwick, et autres
Publié: (2021)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
par: Tran TN, et autres
Publié: (2013)

Mitochondrial Imbalance as a New Approach to the Study of Fibromyalgia
par: Martínez-Lara A, et autres
Publié: (2020)

Treatment of systemic-onset juvenile arthritis with canakinumab
par: Peitz J, et autres
Publié: (2015)

Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
par: Curtis EM, et autres
Publié: (2014)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
par: Murakami M, et autres
Publié: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
par: Murdaca G, et autres
Publié: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
par: Michael G Feely
Publié: (2010)

Long-term use of adalimumab in the treatment of rheumatic diseases
par: Charalampos Papagoras, et autres
Publié: (2009)

Calcium pyrophosphate crystal deposition disease: diagnosis and treatment
par: Rosales-Alexander JL, et autres
Publié: (2014)

Retrospective analysis of treatment modalities in diabetic muscle infarction
par: Onyenemezu I, et autres
Publié: (2014)

New developments in the treatment of osteoarthritis – focus on biologic agents
par: Torrero JI, et autres
Publié: (2015)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
par: Montepaone M, et autres
Publié: (2014)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
par: Augustine JM, et autres
Publié: (2012)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
par: Masahiko Mihara, et autres
Publié: (2011)

Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany
par: Wollenhaupt J, et autres
Publié: (2013)

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
par: Franz Thiele, et autres
Publié: (2021)

Optimal management of dactylitis in patients with psoriatic arthritis
par: Yamamoto T
Publié: (2015)

Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
par: Alisa Carman Gotte
Publié: (2009)

Retrospective analysis of the clinical course of patients treated for polymyalgia
par: Do-Nguyen D, et autres
Publié: (2013)

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
par: Scolnik M, et autres
Publié: (2011)

The use of administrative health care databases to identify patients with rheumatoid arthritis
par: Hanly JG, et autres
Publié: (2015)